ne phosphate (CP)group], and 29 cases (20 male and 9 female) received routine treatment only(routine treatment control group).
1.2Method:
All patients received routine treatment. The patients of CP group received CP(Neoton, Italian pharmaceutical company of Alfa Wassermann)intravenous drip and routine treatment, the method was CP 2g+5%glucose or 0.9% sodium chloride 100ml, iv. drip, for patients with mild diastolic dysfunction was 1time/d, patients with moderate diastolic dysfunction was 2 times/d, duration was 7~14 days.
1.3Curative Effective Standards:
Symptoms: Palpitation, Short of Breath, , Tiredness.
Standards: Marked effective-the symptoms totally disappeared; Effective-the symptoms had been relieved; Ineffective-no any change
Signs: Pulmonary rales and bilateral lower limb edema
Standards: Marked effective-pulmonary rales and bilateral lower limb edema disappeared; Effective-pulmonary rales and bilateral lower limb edema improved; Ineffective-no any change
Others:Blood pressure, heart rhythm, heart rate, early stage of kidney damage, routine blood test, liver function and ECG
Cardiac function:
(1)The equipment used: color Doppler GE V7 and Siemens S2000
(2)Measured method: The E(transmitral peak early diastolic velocity) / A(transmitral peak late diastolic velocity)ratio was measured by Doppler ultrasound blood flow technique.The sample volume was placed at the tip of the mitral valve leaflets in the four-chamber apical view. The Ea(peak early diastolic velocity of mitral annulus)/ Aa(peak late diastolic velocity of mitral annulus)ratio was measured by Doppler ultrasound tissue technique:the sample volume was placed in mitral annulus cross. The E / Ea ratio (left ventricular diastolic function indexes, more than 15 was positive for diastolic heart failure diagnosis, less than 8 was normal for diastolic function, ranging from 8 to 15 was diastolic dysfunction) w
上一页 [1] [2] [3] [4] [5] [6] 下一页